Skip to main navigation Skip to search Skip to main content

Olmesartan improves pulse wave velocity and lowers central systolic blood pressure and ambulatory blood pressure in patients with metabolic syndrome.

  • Ulrike Raff
  • , Stefanie Walker
  • , Christian Ott
  • , Markus Schneider
  • , Roland E Schmieder

Research output: Contribution to journalOriginal Articlepeer-review

5 Citations (Web of Science)
Original languageEnglish
Pages (from-to)98-104
JournalJOURNAL OF CLINICAL HYPERTENSION
Volume17
Issue number2
DOIs
Publication statusPublished - 2015

Keywords

  • PREDICTS CARDIOVASCULAR MORTALITY
  • ARTERIAL STIFFNESS
  • DISEASE
  • AMLODIPINE
  • RISK

Cite this